| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.7M | -29.3% |
| R&D Expense | $47.8M | -13.3% |
| SG&A Expense | $29.2M | -5.0% |
| Operating Income | -$69.0M | +7.4% |
| Pre-tax Income | -$66.3M | +7.2% |
| Income Tax | -$1.5M | +83.8% |
| Net Income | -$64.8M | -4.4% |
| EPS (Basic) | -$0.57 | +6.6% |
| EPS (Diluted) | -$0.57 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.5M | -7.5% |
| Accounts Receivable | $7.4M | +40.2% |
| Inventory | $823K | +1614.6% |
| Current Assets | $65.3M | -4.1% |
| Total Assets | $300.9M | -7.6% |
| Current Liabilities | $16.3M | +7.7% |
| Total Liabilities | $33.9M | -10.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.5M | +8.1% |
| Capital Expenditures | $565K | -69.9% |
| Investing Cash Flow | $6.5M | -82.9% |
| Financing Cash Flow | $27.9M | +114.4% |
| Free Cash Flow | -$37.0M | +10.9% |
| +6.6% |
| Stockholders' Equity |
| $267.0M |
| -7.2% |